Pro-inflammatory cytokine and adhesion molecule pathways

Pro-inflammatory cytokine and adhesion molecule pathways encompass the coordinated signaling networks that regulate the recruitment and activation of immune cells during an inflammatory response. Pro-inflammatory cytokines, such as Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-1 (IL-1), and Interleukin-6 (IL-6), serve as primary triggers that induce the expression of adhesion molecules like ICAM-1, VCAM-1, and selectins on the surface of endothelial cells (PubMed: 11907597). This molecular interaction allows circulating leukocytes to adhere to and migrate through the vascular endothelium into target tissues, a process essential for host defense but detrimental when chronically overactive (StatPearls: NBK482414). In diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease, these pathways are pathologically sustained, leading to chronic tissue destruction and remodeling. Pharmacological intervention typically targets specific nodes within these pathways, such as cytokine neutralization or integrin blockade, to dampen the inflammatory cascade and prevent leukocyte infiltration (NIH: PMC2923847). While highly effective in treating autoimmune conditions, modulating these broad pathways carries significant risks of systemic immunosuppression and increased susceptibility to serious infections.

Other names

Inflammatory signaling cascadesCytokine-mediated adhesion pathwaysLeukocyte recruitment pathwaysCytokine-adhesion molecule axis

Neutralization of pro-inflammatory cytokines or blockade of cell-surface adhesion molecules to inhibit leukocyte recruitment and downstream inflammatory signaling.